Abstract:The study of non-ATP competitive inhibitors of GSK-3β had aroused more and more concern,especially in the area of Alzheimer's disease. Compared w ith ATP competitive inhibitors,non-ATP competitive inhibitors had higher selectivity. Unfortunately,the reported non-ATP competitive inhibitors w ere usually w ith poor inhibitory activities( IC 50 = 1- 100 μmol·L- 1) so far. So it is necessary to find more non-ATP competitive inhibitors. The benzothiazinone compounds w ere designed based on both the core structure of leading compound HZjb( IC 50 = 100 μmol·L- 1) and the side chain of reported novel compound VP 0. 7( IC 50 = 3 μmol·L- 1) guided by the theory of molecular hybridization. Totally twenty two target compounds w ere synthesized and the structures were confirmed by MS and1H-NMR. The inhibitory activities w ere carried out by chemluminescence with TDZD-8 as the reference compound. Among them,IC 50 values of six compounds w ere below the level of 30 μmol·L- 1and the best one 5h( IC 50 = 11. 9 μmol·L- 1) was equivalently active to the reported non-ATP competitive inhibitors. The structure-activity relationships analysis of the benzothiazinones show ed that both the length and the flexibility of side chain w ere of essential important to the activity. Furthermore,the compound 5h w as confirmed by dynamic experiments to be both non-ATP competitive and non-substrate competitive. That kind of compounds w as proposed to be located in the specific allosteric site of GSK-3β.

Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.

Benzamide Derivatives As Dual-Action Hypoglycemic Agents That Inhibit Glycogen Phosphorylase and Activate Glucokinase.

Structure based inhibitor design targeting glycogen phosphorylase B. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-β-d-glucopyranosylamines

In the Search of Glycogen Phosphorylase Inhibitors: Synthesis of C-D-Glycopyranosylbenzo(hydro)quinones – Inhibition of and Binding to Glycogen Phosphorylase in the Crystal

Design, Synthesis, and Evaluation of 3‐aryl‐4‐pyrrolyl‐maleimides As Glycogen Synthase Kinase‐3β Inhibitors

Synthesis, In Silico and Kinetics Evaluation of N-(β-d-glucopyranosyl)-2-arylimidazole-4(5)-carboxamides and N-(β-d-glucopyranosyl)-4(5)-arylimidazole-2-carboxamides as Glycogen Phosphorylase Inhibitors

Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.

Design,synthesis and biological evaluation of benzothiazinones as novel non-ATP competitive inhibitors of glycogen synthesis kinase 3β(GSK-3β)

Identification of Pentacyclic Triterpenes Derivatives As Potent Inhibitors Against Glycogen Phosphorylase Based on 3D-QSAR Studies

Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases.

Synthesis and Biological Evaluation of Substituted Phenylpyrazole[4,5-B]oleanane Derivatives As Inhibitors of Glycogen Phosphorylase.

Discovery of Novel Dual-Action Antidiabetic Agents That Inhibit Glycogen Phosphorylase and Activate Glucokinase

Synthesis and Evaluation of 3-Anilino-quinoxalinones As Glycogen Phosphorylase Inhibitors.

Recent Advances in Design of Glycogen Phosphorylase Inhibitors

Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors.

Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3beta (GSK-3beta) inhibitors.

Synthesis and biological evaluation of novel pyrazolo[4,3-b]oleanane derivatives as inhibitors of glycogen phosphorylase.

Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors

Design, Synthesis, and Pharmacological Evaluation of Benzamide Derivatives As Glucokinase Activators.

Computational Insights into Novel Inhibitor N-(3-(tert-Butylcarbamoyl)-4-methoxyphenyl)-indole and Ingliforib Specific against GP Isoenzyme Dimers Interaction Mechanism

Design, Synthesis and Evaluation of 7-Azaindazolyl-indolyl-maleimides As Glycogen Synthase Kinase-3Β (Gsk-3Β) Inhibitors